In addition to loss/attenuation of PBRM1 expression, tumor size, depth of invasion, histological grade, lymph node metastasis, clinical stage, MSI, sTIL, and iTIL were statistically significant factors for survival time. The gene discussed is PBRM1; the disease is metastatic malignant neoplasm in the lymph nodes.